61
42
Growth Score
-14 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
359621
GenVivo develops gene therapies to treat cancer and prolong patient survival.
- Noriyuki Kasahara: Chief Scientific OfficerPast Role: 4D Molecular Therapeutics, Chief Scientific Officer
About the Company
GenVivo creates novel gene therapies to treat cancer, extend patient survival, and improve quality of life. Their approach to killing tumors while activating the immune system to fight the patient's cancer, combined with the incorporation of novel companion diagnostics, places us at the forefront of cancer immunotherapies and emerging
clinical-stage cancer companies.
